The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency (HEART-FID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03037931
Recruitment Status : Completed
First Posted : January 31, 2017
Last Update Posted : April 26, 2023
Duke Clinical Research Institute
Information provided by (Responsible Party):
American Regent, Inc.

Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the Results Quality Control (QC) review process. Results information is submitted to by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status : Completed
Actual Primary Completion Date : February 2, 2023
Actual Study Completion Date : February 2, 2023
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 2, 2024
February 27, 2024 Submission with QC Comments
2 March 19, 2024
April 16, 2024 Submission with QC Comments
3 May 9, 2024
June 5, 2024 Submission with QC Comments
4 June 7, 2024